Results for Amylin Pharmaceuticals FDA Approval West Chester Ohio

Amylin, Alkermes Diabetes Drug Wins FDA Approval on Third Try

January 27, 2012

Jan. 27 (Bloomberg) -- Amylin Pharmaceuticals Inc. and Alkermes Plc succeeded in their third attempt to gain U.S. clearance for Bydureon, a once-weekly version of Amylin’s diabetes shot.

The Food and Drug Administration approved the drug for adults with Type 2 diabete...

Read More

*